Titer

The Diphtheria and Tetanus Antitoxoids Test measures protective antibody levels to confirm immunity from prior vaccination or exposure. Adequate antibody levels indicate effective protection, while low levels may signal the need for a booster. Doctors use this test to verify immune status for healthcare workers, students, or travelers, and to ensure long-term protection against diphtheria and tetanus infections that can cause serious complications.

The Diphtheria Titer Test measures antibody levels to evaluate immune protection against Corynebacterium diphtheriae, the bacterium that causes diphtheria. This test helps determine whether immunity is adequate following vaccination or exposure. By assessing diphtheria antibody titers, it provides insight into immune system response, vaccine effectiveness, and long-term protection against this serious infection.

The Hepatitis A & B Titer Test Panel is a comprehensive diagnostic tool designed to evaluate an individual's immunity status or infection presence for Hepatitis A and Hepatitis B viruses. This panel combines serological assays that measure specific antibodies and antigens associated with Hepatitis A and B, providing crucial insights for clinical diagnosis, vaccination verification, and the assessment of immune response post-vaccination or post-exposure.

The Hepatitis A Antibody Total Test is a qualitative test that detects antibodies to hepatitis A virus (HAV) and reports results as Reactive or Non-Reactive. It does not distinguish between IgM and IgG antibodies. A reactive result may indicate past infection or immunity from vaccination, while a non-reactive result suggests no prior exposure. Doctors use this test to assess immune status, guide vaccination decisions, and evaluate risk of hepatitis A infection.

The Hepatitis A IgM Antibody Test is a qualitative blood test that detects IgM antibodies to the hepatitis A virus (HAV) and reports results as Reactive or Non-Reactive. A reactive result usually indicates a recent or current hepatitis A infection, while a non-reactive result means no active infection. Doctors use this test to confirm acute hepatitis A in patients with symptoms like jaundice, nausea, fatigue, or abdominal pain and to guide timely treatment and prevention.

The Hepatitis B Core Antibody Total Test is a qualitative blood test that detects antibodies to the hepatitis B core antigen (anti-HBc) and reports results as Reactive or Non-Reactive. A reactive result may indicate past or ongoing infection, while a non-reactive result suggests no exposure. This test does not distinguish between IgM and IgG antibodies. Doctors use it to evaluate hepatitis B exposure, confirm infection history, and assess overall immune response.

The Hepatitis B Immunity Panel Test evaluates immune status by measuring Hepatitis B surface antibody levels in the blood. A positive result typically indicates immunity from vaccination or past infection, while a negative result suggests susceptibility. This test is important for verifying protection, monitoring vaccine response, or determining if additional vaccination or further evaluation for Hepatitis B exposure is needed.

The Hepatitis B Surface Antibody Quantitative Test measures the exact level of anti-HBs antibodies in blood to determine past exposure and whether protective immunity has developed from infection or vaccination. A higher antibody level generally indicates adequate immune response, while a low level suggests limited or no protection. Doctors use this test to confirm vaccine effectiveness, assess immune status, and support hepatitis B screening or preventive care.

The Hepatitis B Surface Antigen (HBsAg) Test with Reflex to Confirmation screens for hepatitis B surface antigen in blood and, if reactive, automatically performs confirmatory testing. A reactive confirmed result indicates an active hepatitis B infection, while a non-reactive result shows no infection. Doctors use this test to diagnose acute or chronic hepatitis B, investigate abnormal liver tests, and guide treatment, monitoring, and infection control decisions.

 The Hepatitis B Titer Test Panel is a diagnostic panel that comprises three essential tests designed to assess immunity, infection status, and antibody levels for the Hepatitis B virus (HBV). The panel includes the following tests: Hepatitis B Core Antibody Total, Hepatitis B Surface Antibody Quantitative, and Hepatitis B Surface Antigen with Reflex Confirmation.

The Measles IgG Antibody Test measures IgG antibodies to determine immunity from past infection or vaccination. A positive result indicates protective immunity, while a negative result suggests susceptibility to measles. Doctors use this blood test to confirm immune status, evaluate vaccination records, or meet school, travel, or employment requirements. It provides valuable insight into measles protection and public health safety.

The MMR Titer Test is a quantitative blood test that measures antibody levels to measles, mumps, and rubella. Results provide exact antibody values to confirm prior infection or response to vaccination. Low levels suggest lack of protection, while higher levels indicate adequate response. Doctors order this test for school, employment, or travel requirements and to guide revaccination decisions, ensuring accurate evaluation of immune status against these viral diseases.

The Rubella IgG IgM Antibodies Test measures antibodies to the rubella virus, helping evaluate immunity or recent infection. IgM indicates an active or recent infection, while IgG confirms past infection or vaccination. Doctors use this test to assess immune status in women of childbearing age, screen during pregnancy, or confirm suspected rubella exposure, as infection can cause serious complications for unborn babies.

The Rubella IgM Antibody Test measures immune response to the rubella virus by identifying IgM antibodies produced soon after exposure. Detection of rubella IgM helps diagnose recent infection, assess rash-related illness, and monitor risk in pregnancy where congenital rubella syndrome may occur. This test provides valuable insight into acute infection, immunity status, and systemic health.

The Syphilis (RPR + FTA-ABS) panel is a diagnostic tool used to detect and confirm the presence of syphilis, a sexually transmitted infection (STI) caused by the bacterium Treponema pallidum. This panel combines two tests: the RPR (Rapid Plasma Reagin) Screen with Reflex to Titer, and the FTA-ABS (Fluorescent Treponemal Antibody Absorption) test, offering both initial screening and confirmatory diagnosis capabilities.

The Tetanus and Diphtheria Titer Test measures antibody levels to determine immunity from prior vaccination or exposure. Adequate titers indicate protective immunity, while low levels may suggest the need for a booster. Doctors order this test for healthcare workers, students, travelers, or those with uncertain vaccination history. It provides essential information for maintaining protection against these serious bacterial infections.

The Tetanus Antitoxoid Test evaluates antibody levels to tetanus toxin, offering information about immune defense and vaccination status. Adequate levels indicate protection, while low results may suggest reduced immunity. This test aids in assessing immune response, monitoring vaccine effectiveness, and identifying systemic conditions that influence antibody production and immune balance.

The Varicella Titer Test is a blood test that measures antibodies to the varicella-zoster virus (VZV), which causes chickenpox and shingles. A positive result indicates past infection, while a negative suggests no exposure. This test is not considered reliable for confirming immunity from vaccination. Doctors use it to evaluate history of natural infection, meet school or work requirements, and provide documentation of varicella exposure status.

The Varicella Zoster Virus IgG IgM Antibodies Panel is used to assess exposure to the varicella-zoster virus, which causes both chickenpox and shingles. By evaluating the presence and levels of specific antibodies, this panel aids in diagnosing current infections, determining immunity, and guiding vaccination decisions.

The Varicella IgM Antibody Test measures IgM antibodies produced in response to varicella-zoster virus, helping identify current or recent chickenpox infection. It aids in differentiating acute illness from prior exposure or immunity. This test supports evaluation of symptoms such as rash, fever, or fatigue, and provides valuable information about immune activity and viral health risks.